Ziad Nahas

Author PubWeight™ 76.58‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015 7.99
2 Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 2007 5.59
3 Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry 2010 3.14
4 Decreased brain activation during a working memory task at rested baseline is associated with vulnerability to sleep deprivation. Sleep 2005 2.04
5 Increased prolactin concentrations in a patient with bipolar disorder. Clin Chem 2013 2.03
6 Vagus nerve stimulation acutely alters food craving in adults with depression. Appetite 2006 1.61
7 Postoperative left prefrontal repetitive transcranial magnetic stimulation reduces patient-controlled analgesia use. Anesthesiology 2006 1.28
8 Estimating resting motor thresholds in transcranial magnetic stimulation research and practice: a computer simulation evaluation of best methods. J ECT 2006 1.27
9 Emotion facilitates action: a transcranial magnetic stimulation study of motor cortex excitability during picture viewing. Psychophysiology 2007 1.26
10 Reducing pain and unpleasantness during repetitive transcranial magnetic stimulation. J ECT 2006 1.22
11 The maximum-likelihood strategy for determining transcranial magnetic stimulation motor threshold, using parameter estimation by sequential testing is faster than conventional methods with similar precision. J ECT 2004 1.19
12 Can left prefrontal rTMS be used as a maintenance treatment for bipolar depression? Depress Anxiety 2004 1.18
13 Decreased cortical response to verbal working memory following sleep deprivation. Sleep 2005 1.18
14 Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol Psychiatry 2002 1.17
15 A review of functional neuroimaging studies of vagus nerve stimulation (VNS). J Psychiatr Res 2003 1.14
16 Fifteen minutes of left prefrontal repetitive transcranial magnetic stimulation acutely increases thermal pain thresholds in healthy adults. Pain Res Manag 2007 1.11
17 More lateral and anterior prefrontal coil location is associated with better repetitive transcranial magnetic stimulation antidepressant response. Biol Psychiatry 2009 1.11
18 Acute left prefrontal transcranial magnetic stimulation in depressed patients is associated with immediately increased activity in prefrontal cortical as well as subcortical regions. Biol Psychiatry 2004 1.07
19 Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimul 2010 1.07
20 A pilot study of functional magnetic resonance imaging brain correlates of deception in healthy young men. J Neuropsychiatry Clin Neurosci 2004 1.06
21 Vagus nerve stimulation (VNS) synchronized BOLD fMRI suggests that VNS in depressed adults has frequency/dose dependent effects. J Psychiatr Res 2002 1.05
22 Safety, tolerability, and effectiveness of high doses of adjunctive daily left prefrontal repetitive transcranial magnetic stimulation for treatment-resistant depression in a clinical setting. J ECT 2011 1.02
23 Significant analgesic effects of one session of postoperative left prefrontal cortex repetitive transcranial magnetic stimulation: a replication study. Brain Stimul 2008 1.00
24 Motor threshold in transcranial magnetic stimulation: the impact of white matter fiber orientation and skull-to-cortex distance. Hum Brain Mapp 2009 1.00
25 Tolerability and safety of high daily doses of repetitive transcranial magnetic stimulation in healthy young men. J ECT 2006 0.98
26 Mechanisms and the current state of transcranial magnetic stimulation. CNS Spectr 2003 0.97
27 Interleaved transcranial magnetic stimulation/functional MRI confirms that lamotrigine inhibits cortical excitability in healthy young men. Neuropsychopharmacology 2004 0.94
28 A single 20 mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in schizophrenia. Schizophr Res 2007 0.94
29 Vagus nerve stimulation for the treatment of depression and other neuropsychiatric disorders. Expert Rev Neurother 2007 0.93
30 A pilot study investigating the effects of fast left prefrontal rTMS on chronic neuropathic pain. Pain Med 2009 0.92
31 Acute vagus nerve stimulation using different pulse widths produces varying brain effects. Biol Psychiatry 2004 0.92
32 Prefrontal cortex transcranial magnetic stimulation does not change local diffusion: a magnetic resonance imaging study in patients with depression. Cogn Behav Neurol 2003 0.91
33 Brain stimulation for the treatment of psychiatric disorders. Curr Opin Psychiatry 2007 0.91
34 Relapse rates with long-term antidepressant drug therapy: a meta-analysis. Hum Psychopharmacol 2009 0.91
35 Neurocognitive deficits and prefrontal cortical atrophy in patients with schizophrenia. Schizophr Res 2007 0.90
36 Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression. Depress Anxiety 2011 0.90
37 Focal electrically administered therapy: device parameter effects on stimulus perception in humans. J ECT 2009 0.89
38 A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders. Brain Stimul 2008 0.88
39 Prefrontal rTMS for treating depression: location and intensity results from the OPT-TMS multi-site clinical trial. Brain Stimul 2012 0.88
40 Mechanisms and state of the art of transcranial magnetic stimulation. J ECT 2002 0.87
41 Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression. Depress Anxiety 2012 0.86
42 A pilot safety study of repetitive transcranial magnetic stimulation (rTMS) in Tourette's syndrome. Cogn Behav Neurol 2004 0.86
43 Novel treatments of mood disorders based on brain circuitry (ECT, MST, TMS, VNS, DBS). Semin Clin Neuropsychiatry 2002 0.86
44 Inverse effects of oxytocin on attributing mental activity to others in depressed and healthy subjects: a double-blind placebo controlled FMRI study. Front Psychiatry 2010 0.86
45 A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia. Schizophr Res 2007 0.85
46 Using interleaved transcranial magnetic stimulation/functional magnetic resonance imaging (fMRI) and dynamic causal modeling to understand the discrete circuit specific changes of medications: lamotrigine and valproic acid changes in motor or prefrontal effective connectivity. Psychiatry Res 2011 0.84
47 Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis. Adv Ther 2009 0.84
48 Vagus nerve stimulation and emotional responses to food among depressed patients. J Diabetes Sci Technol 2007 0.83
49 A pilot functional MRI study of the effects of prefrontal rTMS on pain perception. Pain Med 2013 0.82
50 Functional neuroanatomy of subcomponent cognitive processes involved in verbal working memory. Int J Neurosci 2005 0.82
51 Lamotrigine and valproic acid have different effects on motorcortical neuronal excitability. J Neural Transm (Vienna) 2009 0.81
52 Fractional anisotropy changes after several weeks of daily left high-frequency repetitive transcranial magnetic stimulation of the prefrontal cortex to treat major depression. J ECT 2011 0.81
53 BOLD-fMRI response vs. transcranial magnetic stimulation (TMS) pulse-train length: testing for linearity. J Magn Reson Imaging 2003 0.81
54 Transcranial magnetic stimulation. Neurosurg Clin N Am 2003 0.79
55 Interleaved transcranial magnetic stimulation and fMRI suggests that lamotrigine and valproic acid have different effects on corticolimbic activity. Psychopharmacology (Berl) 2010 0.78
56 A roadmap to parity in mental health financing: the case of Lebanon. J Ment Health Policy Econ 2014 0.78
57 Reply regarding "efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial". Biol Psychiatry 2010 0.78
58 Donepezil effects on mood in patients with schizophrenia and schizoaffective disorder. Int J Neuropsychopharmacol 2005 0.78
59 Reliability and validity of the Arabic Screen for Child Anxiety Related Emotional Disorders (SCARED) in a clinical sample. Psychiatry Res 2013 0.78
60 Validation of an Arabic multi-informant psychiatric diagnostic interview for children and adolescents: development and Well Being Assessment-Arabic (DAWBA-Arabic). Compr Psychiatry 2013 0.77
61 Double-blind donepezil-placebo crossover augmentation study of atypical antipsychotics in chronic, stable schizophrenia: a pilot study. Schizophr Res 2007 0.77
62 Acute and long-term VNS effects on pain perception in a case of treatment-resistant depression. Neurocase 2006 0.76
63 White matter correlates of clinical function in schizophrenia using diffusion tensor imaging. Schizophr Res 2010 0.75
64 Transcranial magnetic stimulation for treating psychiatric conditions: what have we learned so far? Can J Psychiatry 2008 0.75
65 How to assess the role of transcranial magnetic stimulation in nicotine addiction. Biol Psychiatry 2013 0.75
66 Anatomically based targeting of prefrontal cortex for rTMS. Brain Stimul 2011 0.75
67 Neutral face distractors differentiate performance between depressed and healthy adolescents during an emotional working memory task. Eur Child Adolesc Psychiatry 2013 0.75